Cytodyn Inc (CYDY)

[gestalt2]

that is the problem, if this Israeli company can get the funding and stock growth for a treatment that might work a decade from now then shame in cytodyn management for not being able to do the same thing with pro140.

to put this in perspective, if you were big pharma, what would you buy? a company that might have a cure 10 years from now that has not been injected in a human yet, or a company that has a treatment that has been injected in many and works now. if they get 1-2 years of revenue from pro140 that is enough to pay for the investment in this market with a great profit. even if cytodyn is bought out for 1 billion, that's roughly $3-4 a share. i'm hoping for more than that but it seems hard to imagine cytodyn going for less than that.